NKGen Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.01	0.03	0.12	0.35
Cash & Short-Term Investments	0.01	0.03	0.12	0.35
Cash Growth	-99.91%	-77.78%	-66.67%	-
Accounts Receivable	-	-	0.03	-
Other Receivables	0.02	0.03	0.07	0.07
Receivables	0.02	0.03	0.1	0.07
Prepaid Expenses	0.65	1.57	0.13	0.17
Restricted Cash	0.23	0.25	-	-
Other Current Assets	-	0.06	0	0.02
Total Current Assets	0.91	1.93	0.35	0.61
Property, Plant & Equipment	13.99	14.46	15.88	17.37
Other Intangible Assets	0.09	0.09	0.1	0.09
Total Assets	15	16.48	16.33	18.07
Accounts Payable	13.45	11.04	0.98	1.69
Accrued Expenses	2.32	2.27	1.65	0.49
Short-Term Debt	19.7	9.99	11.66	51.15
Current Portion of Leases	0.15	-	0.38	0.46
Other Current Liabilities	0.78	16.15	0.08	1.96
Total Current Liabilities	37.12	39.45	14.74	55.74
Long-Term Debt	10.6	9.93	-	-
Long-Term Leases	0.28	-	-	0.36
Long-Term Deferred Tax Liabilities	0.03	0.03	0.03	0.02
Other Long-Term Liabilities	14.01	25.76	-	-
Total Liabilities	62.05	75.17	14.77	56.12
Common Stock	0	0	0	0.01
Additional Paid-In Capital	130.2	121.73	80.74	14.36
Retained Earnings	-177	-162.13	-79.18	-52.42
Comprehensive Income & Other	-0.25	-18.29	-	-
Shareholders' Equity	-47.05	-58.69	1.56	-38.05
Total Liabilities & Equity	15	16.48	16.33	18.07
Total Debt	30.74	19.92	12.03	51.97
Net Cash (Debt)	-30.73	-19.9	-11.92	-51.62
Net Cash Per Share	-1.27	-1.29	-1.87	-3.62
Filing Date Shares Outstanding	44.95	22.81	32.6	14.25
Total Common Shares Outstanding	35.72	21.89	32.58	14.25
Working Capital	-36.21	-37.52	-14.39	-55.13
Book Value Per Share	-1.32	-2.68	0.05	-2.67
Tangible Book Value	-47.14	-58.79	1.47	-38.14
Tangible Book Value Per Share	-1.32	-2.69	0.05	-2.68
Land	5.03	5.03	5.03	5.03
Buildings	8.33	8.33	8.33	8.31
Machinery	4.8	4.88	4.81	4.71
Leasehold Improvements	0.05	0.05	0.05	0.05

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.